Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Conference item |
| Jazyk: | English |
| Vydáno: |
Journal of Rheumatology
2022
|
| Shrnutí: |
|---|